Sign up to our newsletter
and receive exclusive information and discount coupons straight to your inbox

Top news by writer

Daniel Tomas
Tehnology Writer

HEALTH / The daily deal : a neck massager at an unbeatable price
As of this week, helpmeoutDOC has begun offering a series of massively discounted health items for sale. Today it is time to introduce our readers…
July 28, 2016 | 0 comments

Gabriel Rosoga
Medical and Health Writer

BEAUTY & SKIN CARE / Bee venom serums work miracles on skin
Bee venom, when used in small dosis, proves to be a very effective natural medicine, with extremely beneficial impact on the human organism, with particular…
September 8, 2016 | 1 comment

Ion Gireada
Science Writer

HEALTH / Reasons why your brain hears a ringing
Brain activity in people affected by tinnitus is very different from what happens when sound is detected in brains of healthy people, new research uncovered.…
April 27, 2015 | 0 comments

Ionut Popescu
Health and lifestyle writer

HEALTH / Brits oblivious to obesity leading to cancer
British population largely unware of link between obesity and cancer, finds new survey conducted by the organization Cancer Research UK. According to the survey, 75%…
September 9, 2016 | 0 comments

Drug Nurofen under fire in Australia for misleading claims

by Ion Gireada on 5 March 2015
Health, Lifestyle     |      misleading,  nurofen,  pain relief,  Reckitt Benckiser

The popular drug Nurofen has been associated with attributes like “misleading” on the packaging over “specific pain” products.

The Australian Competition and Consumer Commission (ACCC) has launched legal action against pharmaceutical giant Reckitt Benckiser Australia for the marketing of its Nurofen Specific Pain Product range.

Products considered for this dispute include Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache.

The agency stated that making each product with the impression of addressing a particular type of pain is false or misleading, because the tables are in fact identical.

The drugs, frequently sold at different prices, contain the same active ingredient, specifically ibuprofen lysine 342mg.

ACCC is looking for “penalties and costs” from the UK-based pharmaceutical company, in addition to the “publication of corrective notices”.

ACCC Chairman Rod Sims said Nurofen products were listed on the Australian Register of Therapeutic Goods as able to treat a wide variety of pain types.

“In this case, we allege that consumers have been misled into purchasing Nurofen Specific Pain Products under the belief that each product is specifically designed for and effective in treating a particular type of pain, when this is not the case,” he said.

Reckitt Benckiser Australia however, said in a statement that it challenges any allegations that it had breached consumer law.

“All Nurofen packs are approved by the TGA and comply with TGA’s regulatory guidelines,” the retailer said. “Nurofen pain-specific products provide easier navigation of pain-relief options for a particular type of pain.”

Drug Nurofen under fire in Australia for misleading claims

facebook pinterest google+

  • John G

    Panadol osteo anyone ?